Clinical Trial Update: Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluating time-on-target PET imaging for aprepitant and fosaprepitant in chemotherapy-induced nausea and vomiting has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)
• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting (CINV) | Phase 1 | Status: COMPLETED | Results posted: 2011-11-03